quinoxalines has been researched along with coproporphyrin i in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bow, DAJ; Coppola, S; Kalluri, HV; Kikuchi, R; Mohamed, MF; Salem, AH; Schmidt, J | 1 |
1 trial(s) available for quinoxalines and coproporphyrin i
Article | Year |
---|---|
Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study.
Topics: Adult; Area Under Curve; Benzimidazoles; Biological Availability; Biomarkers, Pharmacological; Coproporphyrins; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Monitoring; Female; Healthy Volunteers; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Prospective Studies; Pyrrolidines; Quinoxalines; Sulfonamides; Young Adult | 2021 |